Embed Size (px)
Citation preview
1
© This is a licensed product of Ken Research and should not be copied
2
© This is a licensed product of Ken Research and should not be copied
TABLE OF CONTENTS 1. India Genomics and Molecular Diagnostics Market Introduction
2. Government Regulations in Diagnostics Market in India
Government Incentives on Diagnostics
Manufacturing License
3. India Molecular Diagnostics Industry - Key Drivers
Rising Incidence of Chronic and Infectious Diseases
Rapidly Ageing Population
Rise in Point of Care Testing
Increased Physician Awareness to Better Clinical Outcomes
Improving Healthcare Infrastructure and Technology in India
Augmenting Purchasing Power and Mounting Health Consciousness
4. India Molecular Diagnostics Market Size, FY’2008-FY’2013
5. India Molecular Diagnostics Market Segmentation, FY’2008-FY’2013
5.1. By Reagents and Instruments, FY’2008-FY’2013
5.1.1. India Molecular Diagnostics Instruments Market Segmentation by Fully Automated and Semi-Automated Analyzers, FY’2008-FY’2013
5.1.2. India Molecular Diagnostics Reagents Market Segmentation by Application, FY’2008-FY’2013
5.1.2.1. India Virology Tests using Molecular Diagnostics Market Size, FY’2008-FY’2013
5.1.2.1.1. India Virology Tests Market Segmentation, FY’2013
5.1.2.2. India Tuberculosis Tests using Molecular Diagnostics Market Size, FY’2008-FY’2013
5.1.2.3. India Cancer Detection using Molecular Diagnostics Market Size, FY’2008-FY’2013
5.1.2.4. India Molecular Blood Screening Tests Market Size, FY’2008-FY’2013
5.1.2.5. India Molecular HPV Tests Market Size, FY’2008-FY’2013
5.1.2.6. India Other Molecular Tests Market Size, FY’2008-FY’2013
5.2. By End-Users, FY’2013
3
© This is a licensed product of Ken Research and should not be copied
5.3. By Manufacturers
6. India Molecular Diagnostics Market Trends and Developments
Innovative Technology Transforming the Clinical Laboratory Medicine Industry
Companion Diagnostics
Mass Spectroscopy Offering One-Step Process
Microfluidic Approach for Point-of-Care (POC) Diagnostics
Rapid Development of Automated Systems
Development of Quicker and Sensitive High-Throughput Systems
7. Market Share of Major Players in India Molecular Diagnostics Market, FY’2013
8. Molecular Diagnostics Products of Major Players
9. Company Profiles of Major Players in India Molecular Diagnostics Market
10. India Genomics and Molecular Diagnostics Market Future Outlook and Projections, FY’2014-FY’2018
India Molecular Diagnostics Reagents Market Future Projections, FY’2014-FY’2018
10.1. Cause and Effect Relationship Analysis of the Molecular Diagnostics Market in India
11. Macro-Economic Factors
11.1. Population in India FY’2008-FY’2018
11.2. Personal Disposable Income in India, FY’2008-FY’2018
11.3. Consumer Expenditure on Healthcare in India, FY’2008-FY’2018
11.4. Government Expenditure on Healthcare in India, FY’2008-FY’2018
11.5. India Medical Devices Market Size, 2008-2018
11.6. FDI in Healthcare in India, FY’2008-FY’2013
12. Appendix
12.1. Market Definitions
12.2. Abbreviations
12.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Final Conclusion
4
© This is a licensed product of Ken Research and should not be copied
12.4. Disclaimer
5
© This is a licensed product of Ken Research and should not be copied
LIST OF FIGURES Figure 1: India Molecular Diagnostics Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
Figure 2: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2008-FY’2013
Figure 3: India Molecular Diagnostics Instrument Market Segmentation by Semi-Automated and Fully Automated Analyzers on the Basis of Revenues in Percentage, FY’2008-FY’2013
Figure 4: India Molecular Diagnostics Reagents Market Segmentation by Application on the Basis of Revenues in Percentage, FY’2008-FY’2013
Figure 5: India Virology Tests Using Molecular Diagnostics Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
Figure 6: India Virology Tests Segmentation on the Basis of Revenue in Percentage, FY’2013
Figure 7: India Tuberculosis Tests Using Molecular Diagnostics Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
Figure 8: India Cancer Detection Using Molecular Diagnostics Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
Figure 9: India Molecular Blood Screening Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
Figure 10: India Molecular HPV Tests Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
Figure 11: India Other Molecular Tests Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
Figure 12: India Molecular Diagnostics Market Segmentation by End-Users on the Basis of Number of Tests, FY’2013
Figure 13: India Molecular Diagnostics Market Segmentation based on Manufacturers by Organized and Home-Brew, FY’2013
Figure 14: Market Share of Major Players on the Basis of Revenues in the India Molecular Diagnostics Market in Percentage, FY’2013
Figure 15: India Molecular Diagnostics Market Future Projections on the Basis of Revenues in INR Million, FY’2014-FY’2018
Figure 16: Population in India in Million, FY’2008-FY’2018
Figure 17: Personal Disposable Incomes in India in INR Million, FY’2008-FY’2018
6
© This is a licensed product of Ken Research and should not be copied
Figure 18: Consumer Expenditure on Healthcare and Medical Services in India in INR Million, FY’2008-FY’2018
Figure 19: Government Expenditure on Health Care in India in INR Million, FY’2008-FY’2018
Figure 20: India Medical Devices Market Size in INR Million, 2008-2018
Figure 21: Foreign Direct Investment in Healthcare Sector in India in INR Million, FY’2008-FY’2013
7
© This is a licensed product of Ken Research and should not be copied
LIST OF TABLES Table 1: Diabetic Population Aged 20-79 Years in India in Million, 2010-2013
Table 2: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in INR Million, FY’2008-FY’2013
Table 3: India Molecular Diagnostics Instrument Market Segmentation by Semi-Automated and Fully Automated Analyzers on the Basis of Revenues in INR Million, FY’2008-FY’2013
Table 4: TB Molecular Diagnostics Methods Endorsed by World Health Organization with Advantages and Limitations
Table 5: Potential Uses of Molecular Diagnostics for Cancer Detection
Table 6: Product Portfolio of Major Players in India Molecular Diagnostics Market
Table 7: Company Profiles of Major Players (Roche Diagnostics, Abbott Laboratories, Qiagen, BioMerieux, Lab India Healthcare) in India Molecular Diagnostics Market
Table 8: India Molecular Diagnostics Reagents Market Future Projections on the Basis of Revenue in INR Million, FY’2014-FY’2018
Table 9: Cause and Effect Relationship Analysis between Industry Factors and Expected Molecular Diagnostics Market Prospects in India
Table 10: Correlation Matrix of the India Molecular Diagnostics Market
Table 11: Regression Coefficients Output
8
© This is a licensed product of Ken Research and should not be copied
INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, FY’2008-FY’2013
The advent of the latest inventions and technologies in accurate detection and quicker screening, and the prolific growth in genetic testing have driven the revenues of the Indian molecular diagnostics market in recent years. The increase in the number of patients stricken with infectious diseases have propelled the revenue growth in FY’2013, where the total turnover was INR ~ million, growing from INR ~ million in FY’2012 by 14.3%...
Figure: India Molecular Diagnostics Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
0.0
100.0
200.0
300.0
400.0
500.0
600.0
700.0
800.0
900.0
1,000.0
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
INR
Mill
ion
9
© This is a licensed product of Ken Research and should not be copied
INDIA MOLECULAR DIAGNOSTICS MARKET SEGMENTATION, FY’2008-FY’2013
BY REAGENTS AND INSTRUMENTS, FY’2008-FY’2013
Reagents led the revenues from the molecular diagnostics space with a percentage contribution of ~% of the total market in fiscal year 2013. The market has transformed from being a labor intensive to the inclusion of latest technologies. Majority of the reagents sales have historically been attributed to the diagnosis of infectious diseases such as tuberculosis, gonorrhea, Chlamydia and influenza virus, as well as the identification and predisposition to several conditions such as cancer and cystic fibrosis…
Figure: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in Percentage, FY’2008-FY’2013
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
100.0%
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
Perc
enta
ge
Reagents Instruments
10
© This is a licensed product of Ken Research and should not be copied
Table: India Molecular Diagnostics Market Segmentation on the Basis of Revenues from Reagents and Instruments in INR Million, FY’2008-FY’2013
Category FY’2008 FY’2009 FY’2010 FY’2011 FY’2012 FY’2013
Reagents
Instruments
INDIA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET SEGMENTATION BY FULLY AUTOMATED AND SEMI-AUTOMATED ANALYZERS, FY’2008-FY’2013
…Since majority of the laboratories in India suffer with budget constraints, the share of fully automated analyzers has been considerably lower in India, accounting for approximately ~% in FY’2013. The fully automated analyzers witnessed sales of total 6 units in FY’ 2012. Abbott and Qiagen are the major players catering to the fully automated analyzers market…
Figure: India Molecular Diagnostics Instrument Market Segmentation by Semi-Automated and Fully Automated Analyzers on the Basis of Revenues in Percentage, FY’2008-FY’2013
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
100.0%
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
Perc
enta
ge
Fully Automated Analyzers Semi-Automated Analyzers
11
© This is a licensed product of Ken Research and should not be copied
INDIA MOLECULAR DIAGNOSTICS REAGENTS MARKET SEGMENTATION BY APPLICATION, FY’2008-FY’2013
…The molecular diagnostics market in India is majorly dominated by the virology tests market with a share of ~% in FY’2013. The infectious diseases such as HIV, HPV, hepatitis B and C and tuberculosis are prevalent in India. The outbreak of diseases such as H1N1 and the rising incidence of diseases such as HIV and hepatitis have augmented the growth of this segment in the molecular diagnostics market of India…
…Cancer detection using molecular diagnosis tests held a share of ~% in FY’2013. Cancer is detected using molecular diagnostics by mainly using technology such as mass spectrometry and gene chips. Molecular diagnostics determines how the genes and proteins are interacting in a cell in the patient’s body…
Figure: India Molecular Diagnostics Reagents Market Segmentation by Application on the Basis of Revenues in Percentage, FY’2008-FY’2013
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
100.0%
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
Perc
enta
ge
Virology Tests Tuberculosis Testing Cancer Detection Blood Screening HPV Testing Others
12
© This is a licensed product of Ken Research and should not be copied
INDIA VIROLOGY TESTS USING MOLECULAR DIAGNOSTICS MARKET SIZE, FY’2008-FY’2013
…Additionally, it has been observed that every year, one million Indians are at a risk of HBV and about 100,000 patients die due to HBV infection in India. Thus, the growing number of incidence of infectious diseases along with rapid development of automated systems and point of care testing has added to the throughput of molecular testing market in the country during FY’2008-FY’2013. The revenues generated by the molecular virology tests market surged from INR ~ million in FY’2008 to INR ~ million in FY’2013, at a CAGR of 3.6% during FY’2008-FY’2013…
Figure: India Virology Tests Using Molecular Diagnostics Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
0.0
50.0
100.0
150.0
200.0
250.0
300.0
350.0
400.0
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
INR
Mill
ion
13
© This is a licensed product of Ken Research and should not be copied
INDIA TUBERCULOSIS TESTS USING MOLECULAR DIAGNOSTICS MARKET SIZE, FY’2008-FY’2013
…RNTCP is a key driver for the growth of tuberculosis testing in the country. The tuberculosis testing market using molecular diagnostics has grown at a CAGR of 6.9% during FY’2008-FY’2013. The Government of India focuses on decreasing the burden of the disease and efficient implementation of reducing TB occurrence in the country will require allocation of enormous funds. The estimated funding requirement for TB control in India under the 12th Five Year Plan period is INR ~ million…
Figure: India Tuberculosis Tests Using Molecular Diagnostics Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
INDIA CANCER DETECTION USING MOLECULAR DIAGNOSTICS MARKET SIZE, FY’2008-FY’2013
…Molecular diagnostics is used for the detection of cancer such as colorectal cancer, prostate cancer, breast cancer, lung cancer, kidney and other cancer. The molecular diagnostics testing for cancer detection market has grown at a CAGR of 7.4% during FY’2008-FY’2013. The revenue generated by this market increased from INR ~ million in FY’2008 to INR ~ million in FY’2013…
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
INR
Mill
ion
14
© This is a licensed product of Ken Research and should not be copied
Figure: India Cancer Detection Using Molecular Diagnostics Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
INDIA MOLECULAR BLOOD SCREENING TESTS MARKET SIZE, FY’2008-FY’2013
Blood screening tests using molecular diagnostics are used to detect HIV, HBV and HCV. Blood screening is done using enzyme-linked immunosorbent assay (ELISA) method. ELISA is not considered to be safe as the Indian Council of Medical Research observed that for every 1,528 units of blood screened, HIV remained undetected in average of three cases. This was mainly because the blood banks lack appropriate screening processes of blood units in the country. The blood screening tests market has grown at a CAGR of 6.4% during FY’2008-FY’2013…
0.0
20.0
40.0
60.0
80.0
100.0
120.0
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
INR
Mill
ion
15
© This is a licensed product of Ken Research and should not be copied
Figure: India Molecular Blood Screening Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
INDIA MOLECULAR HPV TESTS MARKET SIZE, FY’2008-FY’2013
…The rising occurrence of cervical cancer has led to an increase in the number of HPV tests via molecular diagnostics in the country. The revenue witnessed by the HPV testing market in FY’2013 was INR ~ million, which has grown at a CAGR of 8.8% during FY’2008-FY’2013.
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
INR
Mill
ion
16
© This is a licensed product of Ken Research and should not be copied
Figure: India Molecular HPV Tests Market Size on the Basis of Revenues in INR Million, FY’2008-FY’2013
BY END-USERS, FY’2013
…The clinical laboratories held a share of ~% to the overall molecular diagnostics market in FY’2013. Hospitals such as Medicity, Apollo, Max Hospitals and other hospitals in the country also conduct molecular diagnostics testing in their respective laboratories, however, the share of hospitals was ~% which is less when compared to clinical laboratories in the molecular diagnostics market of India…
Table: India Molecular Diagnostics Market Segmentation by End-Users on the Basis of Number of Tests, FY’2013
India Molecular Diagnostics Market Segmentation by End Users FY’2013
Clinical Laboratories
Hospitals
Total
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
FY'2008 FY'2009 FY'2010 FY'2011 FY'2012 FY'2013
INR
Mill
ion
17
© This is a licensed product of Ken Research and should not be copied
BY MANUFACTURERS
The molecular diagnostics market in India is also segmented on the basis of registered manufacturers and in-house protocols (home-brew segment). The organized market for molecular diagnostics market in India is comprised of registered companies which supply molecular diagnostics instruments and reagents. The organized market captured a share of ~% in FY’2013 in the molecular diagnostics market of India…
Table: India Molecular Diagnostics Market Segmentation based on Manufacturers by Organized and Home-Brew, FY’2013
India Molecular Diagnostics Market Segmentation by Manufacturers FY’2013
Organized
Home Brew
Total
MARKET SHARE OF MAJOR PLAYERS IN INDIA MOLECULAR DIAGNOSTICS MARKET, FY’2013
Roche Diagnostics was the largest player in the Indian molecular diagnostics market with a market share of ~% in FY’2013. Roche molecular diagnostics is engaged in the manufacturing of innovative tests based on polymerase chain reaction (PCR). The company also offers tests for blood screening systems which detect the blood infections effectively…
Table: Market Share of Major Players on the Basis of Revenues in the India Molecular Diagnostics Market in Percentage, FY’2013
Market Share of Major Players in India Molecular Diagnostics Market FY’2013
Roche
Abbott
Qiagen
Biomeriux
Others
18
© This is a licensed product of Ken Research and should not be copied
INDIA GENOMICS AND MOLECULAR DIAGNOSTICS MARKET FUTURE OUTLOOK AND PROJECTIONS, FY’2014-FY’2018
… The new molecular technologies are making it possible to collect more information in order to fully understand the disease state to provide best treatment alternatives for a patient. The practical applications of these methods are being met by integration of molecular methods with advanced information technology and data analytic methods. The overall molecular diagnostics market in India is expected to grow at a CAGR of 15.4% during FY’2013-FY’2018, witnessing revenues worth INR ~million by FY’2018.
Figure: India Molecular Diagnostics Market Future Projections on the Basis of Revenues in INR Million, FY’2014-FY’2018
0.0
200.0
400.0
600.0
800.0
1,000.0
1,200.0
1,400.0
1,600.0
1,800.0
2,000.0
FY'2014 FY'2015 FY'2016 FY'2017 FY'2018
INR
Mill
ion
19
© This is a licensed product of Ken Research and should not be copied
INDIA MOLECULAR DIAGNOSTICS REAGENTS MARKET FUTURE PROJECTIONS, FY’2014-FY’2018
Virology segment will continue to dominate the revenues from molecular diagnostics market in India in the coming years. The growing prevalence of infectious diseases in the country is likely to spur the demand for molecular diagnostics based virology tests in the near future. Growth in the forthcoming years will also be driven by rapid technology developments...
Table: India Molecular Diagnostics Reagents Market Future Projections on the Basis of Revenue in INR Million, FY’2014-FY’2018
India Molecular Diagnostics Reagents Market Future Projections in INR Million
FY’2014 FY’2015 FY’2016 FY’2017 FY’2018
Virology Test
Tuberculosis Test
Cancer Detection
Blood Screening
HPV Testing
Others
20
© This is a licensed product of Ken Research and should not be copied
DISCLAIMER
The research reports provided by Ken Research are for the personal information of the authorized recipient and is not for public distribution and should not be reproduced or redistributed without prior permission. You are permitted to print or download extracts from this material for your personal use only. None of this material may be used for any commercial or public use.
The information provided in the research documents is from publicly available data and other sources, which are reliable. Efforts are made to try and ensure accuracy of data. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use will not infringe privately owned rights.
The report also includes analysis and views expressed by our research team. The research reports are purely for information purposes. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Investors should not solely rely on the information contained in the research documents and must make investment decisions based on their own investment objectives, risk profile and financial position. The recipients of this material should take their own professional advice before acting on this information.
Ken Research will not accept returns of reports once dispatched due to the confidentiality of information provided in our reports. In case, a report qualify for return, we will issue a credit, minus shipping charges, of equal value to the original purchase price, toward a future purchase—no refunds. The decision about whether the product return can be accepted or not is solely at our discretion. Any dispute will be subject to the laws of India and exclusive jurisdiction of Indian Courts.
No part of this manual or any material appearing may be reproduced, stored in or transmitted on any other Web site without written permission of Ken Research and any payments of a specified fee. Requests to republish any material may be sent to us.
